MAPK3 and Alzheimer disease: Persistent upregulation in p-ERK1/2 may be involved in AD pathogenesis through its phosphorylation resulting in proliferation, activation of microglial cells, and secretion of cytokines which interfere with the role of BDNF as a neuroprotective and anti-inflammatory mediator.